Pre-market Hot Trades in US Stocks

Outlook Therapeutics is down 8.99% in pre-market trading. Based on recent key news:

1. On July 24, Outlook Therapeutics announced that its drug Lytenava received FDA approval for the treatment of wet age-related macular degeneration (AMD). This approval marks the company's first entry into the US market and is expected to have a 12-year market exclusivity. Following the announcement, the company's stock price rose by 18%.

2. On July 25, Outlook Therapeutics' stock price fell 8.99% in pre-market trading. Despite the FDA approval of its drug, there remains uncertainty in the market regarding its future commercialization and market acceptance, leading to stock price volatility.

3. On July 27, Outlook Therapeutics' stock price continued to decline, dropping by 9.60%. Although the company is actively preparing for the commercial promotion of the drug, investors remain cautious about its long-term performance. The ophthalmic market is highly competitive, and capital flows are significant.

Advanced Semiconductor Engineering is down 7.52% in pre-market trading. Based on recent key news:

1. On July 26, Nomura Securities released a report on the AI semiconductor industry, indicating that AI concept stocks have recently consolidated, but component shortages and price hikes will act as catalysts. Advanced Semiconductor Engineering was given a "Buy" rating with a target price of 730 TWD. Despite the positive rating, market concerns about capital expenditure outlooks from cloud service providers may impact stock prices.

2. On July 27, Intel's earnings report showed strong demand for server CPUs driven by AI, benefiting Advanced Semiconductor Engineering as a packaging manufacturer. Bank of America and UBS are optimistic about Advanced Semiconductor Engineering's profit upgrades, although the stock price has lagged.

3. On July 26, a report from Knight Frank indicated that Advanced Semiconductor Engineering is active in the commercial real estate market in Taiwan, with total transaction amounts reaching 42.5 billion TWD, demonstrating strong demand in the industrial real estate sector. The AI industry is consolidating, and the impact of component shortages is significant.

Top Gainers in Pre-market US Stocks

C3is is up 111.91% in pre-market trading. Based on recent key news:

1. On July 27, C3is announced a public offering at a price of $0.52 per unit, with expected total proceeds of approximately $6 million. This move has increased market confidence in the company's liquidity, driving the stock price up. Source: Reuters

2. On July 25, C3is executed a 1-for-7 reverse stock split to regain compliance and expand its fleet, while reporting a 358% surge in adjusted net income for the first quarter to $5.5 million. This financial performance has bolstered investor confidence in the company's growth potential. Source: Zhitong Finance

3. On July 27, C3is entered the US capital market through an SEC registration statement and underwriting of a public offering, utilizing equity and warrant structures to fund its operations and growth plans. This move further solidifies the company's position in the capital market Source: Reuters The shipping industry has performed strongly recently, with significant capital inflows.

Inlif pre-market rose 36.58%. Based on recent key news:

1. On July 24, the Securities and Exchange Commission announced that Inlif disclosed new financial information, showing a significant improvement in its performance, driving the stock price sharply higher.

2. On July 25, the European Investment Bank announced a delay in loan payments to Brenmiller Energy, alleviating market concerns about the company's financial pressure, indirectly affecting the performance of related industry stocks.

3. On July 28, Robo.ai Inc fell 6.3% in pre-market trading after rising 14% the previous day, reflecting market concerns about the volatility of tech stocks. Tech stocks have been quite volatile recently, and attention should be paid to changes in market sentiment.

T3 Defense pre-market rose 34.50%. Based on recent key news:

1. On July 24, T3 Defense submitted a SCHEDULE 13D filing, indicating its strategic acquisition plans. The company focuses on acquiring and improving operational businesses, planning to expand its strategic holdings through follow-up transactions and close collaboration with management. This news boosted market confidence and drove the stock price up.

2. No other significant news recently. The market reacted positively to the strategic acquisition plans